Trilantic North America inks $945m sale of SOFIE Biosciences to GE HealthCare

SOFIE Biosciences runs a US network of 15 contract manufacturing sites operating 21 cyclotrons for PET radiopharmaceuticals.

5 October 2026•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.